India, March 19 -- Stocks have moved mostly higher during trading on Wednesday, regaining ground following the sharp pullback seen in the previous session. The major averages have all moved back to th... Read More
India, March 19 -- Cryptocurrencies recorded a major price surge in response to a post by the CEO of Ripple Labs that his company's legal battle with the Securities and Exchange Commission has ended. ... Read More
India, March 19 -- Shares of Regenxbio Inc. (RGNX) gained 5% on Wednesday morning after the company reported positive biomarker data from Affinity Duchenne trial of RGX-202 gene therapy. RGNX is curr... Read More
India, March 19 -- Crude oil inventories in the U.S. increased by more than expected in the week ended March 14th, according to a report released by the Energy Information Administration on Wednesday.... Read More
India, March 19 -- Enerflex Ltd. (EFXT, EFX.TO) announced that Marc Rossiter has stepped down as President, Chief Executive officer, and Director, effective immediately. Preet Dhindsa, Enerflexs curr... Read More
India, March 19 -- Shares of Vestis Corporation (VSTS) slipped over seven percent on Wednesday morning after the company announced the departure of its Financial Chief Kim Scott. VSTS is currently tr... Read More
India, March 19 -- German real estate major Vonovia SE reported Wednesday a net loss in fiscal 2024, but significantly narrower than last year, mainly with growth in revenues. The company also announc... Read More
India, March 19 -- Shares of Black Diamond Therapeutics, Inc. (BDTX) jumped over 27% on Wednesday morning after the clinical-stage oncology company and Servier, an independent global pharmaceutical gr... Read More
India, March 19 -- The RADIANT trial conducted by Insulet Corp. (PODD) highlighted significant glycemic improvements with the use of the Omnipod 5 Automated Insulin Delivery System. These improvements... Read More
India, March 19 -- Acumen Pharmaceuticals, Inc. (ABOS), a clinical-stage biopharmaceutical company, Wednesday announced topline data from Phase 1 study of its drug candidate sabirnetug, which is being... Read More